Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 10
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Olasupo OO, Haddix C, Nakar C, Maahs J, Greist A, Ghafoor A, Donfield SM, Iorio A, Shapiro AD | 2022 | Eur J Haematol | View Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders | Health care providers | Benchmarking and standard setting |
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Caffrey N, Goldman M, Osmond L, Yi Q-L, Fan W, O'Brien SF | 2022 | Transfusion | View HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada | Regulators | MSM research |
Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Balitsky A, Arnold D | 2022 | Transfusion | View Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Health care providers | Clinical research |
A cross-sectional study of haemolytic disease of the newborn in Uganda | Dhabangi A, Nankunda J, Okaba V, Nakubulwa S, Hume HA, Dzik WH, Heddle NM | 2022 | Vox Sang | View A cross-sectional study of haemolytic disease of the newborn in Uganda | Health care providers | Clinical research |
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Hillis C, Vicente C, Ball G | 2022 | Pharmacoeconomics | View The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Researchers | Clinical research |
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Qi X, Hatami S, Bozso S, Buchko M, Forgie KA, Olafson C, Khan M, Himmat S, Wang X, Nobes DS, Acker JP, Nagendran J, Freed DH | 2022 | J Heart Lung Transplant | View The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Researchers | Basic research |
Summary of adverse transfusion reactions 2017-2022 | Yan M | 2022 | Blood.ca website | View Summary of adverse transfusion reactions 2017-2022 | Blood operators | Benchmarking and standard setting |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Drews S, Devine D, McManus J, Mendoza E, Manguiat K, Girardin R, Dupuis A, McDonough K, Lin J, Evans D, Pambrun C, Drebot M, Wood H | 2022 | Transfus Med Rev | View Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Blood operators | New or improved product or process |
Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Boligan KF, Sandhu G, Branch DR | 2022 | Curr Protoc | View Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Researchers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Relevé des maladies transmissibles au Canada | View Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | Health care providers | New or improved product or process |
A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Armstrong JP, Brennan DJ, Collict D, Kesler M, Bekele T, Souleymanov R, Grace D, Lachowsky NJ, Hart TA, Adam BD | 2022 | BMC Public Health | View A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Researchers | MSM research |
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Castillo G, Vesnaver E, Gibson E, Butler-Foster T, Goldman M, Hill NE, Rosser A, Lapierre D, Rubini KA, MacDonagh R, Miguel G, Palumbo A, MacPherson P, Randall T, Osbourne-Sorrell W, O'Brien SF, Bridel W, Otis J, Greaves M, Al-Bakri TB, Reid M, Labrecque M, Germain M, Orvis S, Clapperton AT, Devine D, Presseau J | 2022 | Transfusion | View Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Blood operators | MSM research |
A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM | 2022 | Ann Emerg Med | View A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Researchers | Clinical research |
Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Health care providers | Benchmarking and standard setting |
T cell-mediated autoimmunity in immune thrombocytopenia | Vrbensky JR, Nazy I, Clare R, Larché M, Arnold DM | 2022 | Eur J Haematol | View T cell-mediated autoimmunity in immune thrombocytopenia | Researchers | Clinical research |
Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Obaidallah N, Downie H, Colavecchia C, Callum J, Lin Y | 2022 | Transfusion | View Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Health care providers | New or improved product or process |
Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Bartoszko J, Martinez-Perez S, Callum J, Karkouti K, Farouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke H-P, Carroll J, Grewal D, Brar S, Brussières J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M | 2022 | Br J Anaesth | View Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Researchers | Clinical research |
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Dibernardo A, Toledo NP, Robinson A, Osiowy C, Giles E, Day J, Lindsay LR, Drebot MA, Booth TF, Pidduck T, Baily A, Charlton CL, Tipples G, Kanji JN, Brochu G, Lang A, Therrien C, Bélanger-Collard M, Beaulac S-N, Gilfix BM, Boivin G, Hamelin M-È, Carbonneau J, Lévesque S, Martin P, Finzi A, Gendron-Lepage G, Goyette G, Benlarbi M, Gasser R, Fortin C, Martel-Lafferrière V, Lavoie M, Guérin R, Haraoui L-P, Renaud C, Jenkins C, O'Brien SF, Drews SJ, Conrod V, Tran V, Awrey B, Scheuermann R, DuPuis A, Payne A, Warszycki C, Girardin R, Lee W, Zahariadis G, Jiao L, Needle R, Cordenbach J, Zaharatos J, Taylor K, Teltscher M, Miller M, Elsherif M, Robertson P, Robinson JL | 2022 | J Assoc Med Microbiol Infect Dis Can | View Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Researchers | Benchmarking and standard setting |
The bending rigidity of the red blood cell cytoplasmic membrane | Himbert S, D’Alessandro A, Qadri SM, Majcher MJ, Hoare T, Sheffield WP, Nagao M, Nagle JF, Rheinstädter MC | 2022 | PLoS One | View The bending rigidity of the red blood cell cytoplasmic membrane | Researchers | Basic research |
FAQ: Information for health professionals on pathogen-reduced platelets | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ: Information for health professionals on pathogen-reduced platelets | Health care providers | New or improved product or process |
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K, Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Blood operators | Benchmarking and standard setting |
Sommaire des réactions transfusionnelles indésirables | Yan M | 2022 | Blood.ca website | View Sommaire des réactions transfusionnelles indésirables | Blood operators | Benchmarking and standard setting |
Pathogen-reduced buffy coat platelets | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Pathogen-reduced buffy coat platelets | Health care providers | Benchmarking and standard setting |
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Al-Riyami AZ, Estcourt L, Rahimi-Levene N, Bloch EM, Goel R, Tiberghien P, Thibert J-B, Bruun MT, Devine DV, Gammon RR, Wendel S, Toungouz Nevessignsky M, Grubovic Rastvorceva RM, Oreh A, Romon I, van den Berg K, Kitazawa J, Patidar G, So-Osman C, Wood EM, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Health care providers | Clinical research |
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Bowman M, Casey L, Selvam SN, Lima PDA, Rawley O, Hinds M, Tuttle A, Grabell J, Iorio A, Walker I, Lillicrap D, James P | 2022 | J Thromb Haemost | View von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Researchers | Basic research |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Liu B, Hadzi-Tosev M, Liu Y, Lucier KJ, Garg A, Li S, Heddle NM, Rochwerg B, Ning S | 2022 | Crit Care Explor | View Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Health care providers | Clinical research |
A Primer on Biostatistics | Shih AW, Li N, Montemayor C, Heddle NM | 2022 | Practical Transfusion Medicine | View A Primer on Biostatistics | Health care providers | Benchmarking and standard setting |
Hypothermic storage of leukoreduced red blood cells for greater than 21-days is a safe alternative to irradiation | Mykhailova O, Turner TR, Olafson C, Howell A, Nahirniak SN, Wizniak J, Gerges HYN, Baldwin T, Clarke G, Acker JP | 2021 | Transfusion | View Hypothermic storage of leukoreduced red blood cells for greater than 21-days is a safe alternative to irradiation | Researchers | New or improved product or process |
Multicenter observational study evaluating the impact of platelet transport bags on product wastage | Kron A, Vijenthira S, Pendergrast J, Modi D, McLaren A, MacDonald A, Armali C, Cserti-Gazdewich C, Smith E, Quest G, Gabanowicz K, Lieberman L, Aseltine L, Sani L, Roche M, DeOliviera M, Yu P, Fazari S, Patel S, Lin Y, Kelly Z, Callum J | 2021 | Transfusion | View Multicenter observational study evaluating the impact of platelet transport bags on product wastage | Researchers | New or improved product or process |
Magnetic resonance imaging in boys with severe hemophilia A: Serial and end-of-study findings from the Canadian Hemophilia Primary Prophylaxis Study | Stimec J, Dover S, Pullenayegum E, Blanchette VS, Doria AS, Feldman BM, Carcao M, Rivard GE, Israels SJ, Chan AK, Steele M, Cloutier S, Klaassen RJ, Price VE, Sinha R, Laferriere N, Paradis E, Wu JKM, Babyn P | 2021 | Res Pract Thromb Haemost | View Magnetic resonance imaging in boys with severe hemophilia A: Serial and end-of-study findings from the Canadian Hemophilia Primary Prophylaxis Study | Researchers | Clinical research |
Ex vivo hemostatic and immuno-inflammatory profiles of freeze-dried plasma | Peng HT, Rhind SG, Devine D, Jenkins C, Beckett A | 2021 | Transfusion | View Ex vivo hemostatic and immuno-inflammatory profiles of freeze-dried plasma | Researchers | Clinical research |
Research Unit: A more accurate and efficient way to manage blood demand and supply | Li N | 2021 | Blood.ca website | View Research Unit: A more accurate and efficient way to manage blood demand and supply | Health care providers | New or improved product or process |
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia | Huynh A, Kelton JG, Arnold DM, Daka M, Nazy I | 2021 | Nature | View Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia | Researchers | Clinical research |
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography | Chung J, Stevic I, Gantioqui J, Atkinson H, Chan AKC, Chan HHW | 2021 | Blood Coagul Fibrinolysis | View Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography | Researchers | Clinical research |
The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial | Bartoszko J, Callum J, Karkouti K | 2021 | Can J Anaesth | View The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial | Researchers | Clinical research |
Administration de produits sanguins | O'Reilly C | 2021 | Guide de la pratique transfusionnelle | View Administration de produits sanguins | Health care providers | Benchmarking and standard setting |
The Monocyte Monolayer Assay to Build a Personalized Pipeline of Transfusion Support in Highly Sensitized Sickle Cell Disease | Vijenthira S, Nguyen J, Branch DR, Clarke G, Ward R, Saeed S, Cserti-Gazdewich C | 2021 | Blood | View The Monocyte Monolayer Assay to Build a Personalized Pipeline of Transfusion Support in Highly Sensitized Sickle Cell Disease | Health care providers | New or improved product or process |
Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis | Sklavounos AA, Lamanna J, Modi D, Gupta S, Mariakakis A, Callum J, Wheeler AR | 2021 | Clin Chem | View Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis | Researchers | New or improved product or process |
The estimated risk of SARS-CoV- 2 infection via cornea transplant in Canada | O’Brien SF, Lewin A, Yi Q-L, Dowling G, Fissette E, Drews SJ | 2021 | Cell Tissue Bank | View The estimated risk of SARS-CoV- 2 infection via cornea transplant in Canada | Health care providers | Clinical research |
Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion | Ebraheem MS, Verhovsek M | 2021 | Blood Adv | View Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion | Health care providers | Clinical research |
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses | Al-Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kuma? LT, Sa?dur L, Pelit NB, Bazin R, Hindawi SI, Badawi MA, Patidar GK, Pandey HC, Chaurasia R, Fachini RM, Scuracchio P, Wendel S, Ang AL, Ong KH, Young P, Ihalainen J, Vierikko A, Qiu Y, Yang R, Xu H, Rahimi-Levene N, Shinar E, Izak M, Gonzalez CA, Ferrari DM, Cini PV, Aditya RN, Sharma RR, Sachdev S, Hans R, Lamba DS, Nissen-Meyer LSH, Devine DV, Lee CK, Leung JN-S, Hung IFN, Tiberghien P, Gallian P, Morel P, Al Maamari K, Al-Hinai Z, Vrielink H, So-Osman C, De Angelis V, Berti P, Ostuni A, Marano G, Nevessignsky MT, El Ekiaby M, Daly J, Hoad V, Kim S, van den Berg K, Vermeulen M, Glatt TN, Schäfer R, Reik R, Gammon R, Lopez M, Estcourt L, MacLennan S, Roberts D, Louw V, Dunbar N | 2021 | Vox Sang | View International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses | Researchers | Clinical research |
Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances | McVey MJ, Cohen R, Arsenault V, Escorcia A, Tasmin F, Pendergrast J, Lieberman L, Lin Y, Callum J, Cserti-Gazdewich C | 2021 | Vox Sang | View Frequency and timing of all-cause deaths in visits involving suspected transfusion reactions, and the significance of cardiopulmonary disturbances | Health care providers | Clinical research |
Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant | Hamada M, Bhakta V, Andres SN, Sheffield WP | 2021 | Front Cardiovasc Med | View Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant | Researchers | Basic research |
International Forum on Walking Blood Bank Programmes: Responses | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Nadarajan VS, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Responses | Blood operators | New or improved product or process |